Effects of intra-arterial infusion of 3-bromopyruvate on metastases and survival benefit of hepatic VX2 tumor in rabbits

National Medical Journal of China

Volumn 93, Issue 39, 2013, Pages 3139-3142

  Jiang, Xiong Ying ^b   Zhang, Xiao Ping ^a   Huang, Jin Hua ^a   Luo, Rong Guang ^a   Miao, Bi Jian ^a   Wang, Yan ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b NONE

Author keywords

Models, animal; Neoplasm metastasis; Pyruvic acid

Indexed keywords

BROMOPYRUVIC ACID; PHOSPHATE BUFFERED SALINE; PYRUVIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; HEPATIC ARTERY; KIDNEY METASTASIS; LIVER METASTASIS; LIVER TUMOR; LUNG METASTASIS; NONHUMAN; PERITONEAL CAVITY; RABBIT; SURVIVAL TIME;

ANIMALS; LIVER NEOPLASMS, EXPERIMENTAL; NEOPLASM METASTASIS; PYRUVATES; RABBITS; SURVIVAL ANALYSIS;

EID: 84887284417     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2013.39.013     Document Type: Article

References (14)

1. Dell'Antone P. Targets of 3-bromopyruvate, a new, energy depleting, anticancer agent. Med Chem, 2009, 5: 491-496.
2. 2009, 18: 793-796.
3. Gatenby R A, Gillies R J. Why do cancers have high aerobic glycolysis? Nat Rev Cancer, 2004, 4: 891-899.
4. 2007, 87: 1058-1062.
5. Vali M, Liapi E, Kowalski J, et al. Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer. J Vasc Interv Radiol, 2007, 18: 95-101.
6. 2011, 20: 214-217.
7. Vali M, Vossen J A, Buijs M, et al. Targeting of VX2 rabbit liver tumor by selective delivery of 3-bromopyruvate: a biodistribution and survival study. J Pharmacol Exp Ther, 2008, 327: 32-37.
8. Pedersen P L. Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers'most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr, 2007, 39: 211-222.
9. 2012, 32: 108-112.
10. Liu X H, Zheng X F, Wang Y L. Inhibitive effect of 3-bromopyruvic acid on human breast cancer MCF-7 cells involves cell cycle arrest and apoptotic induction. Chin Med J (Engl), 2009, 122: 1681-1685.
11. Xu R H, Pelicano H, Zhou Y, et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res, 2005, 65: 613-621.
12. Geschwind J F, Ko Y H, Torbenson M S, et al. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res, 2002, 62: 3909-3913.
13. 2003, 19: 97-99.
14. Jiang H J, Lu H B, Zhang Z R, et al. Experimental study on angiogenesis in a rabbit VX2 early liver tumour by perfusion computed tomography. J Int Med Res, 2010, 38: 929-939.